Lakefront Biotherapeutics | GLPG - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
AstraZeneca USD 1.55B 73K 2026-03
Biogen USD 146.7M 200K 2025-09
Genmab DKK 61.62M 52K 2025-12
Gilead Sciences USD 1.24B 1000K 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
GRIFOLS EUR 680.58M 0 2026-03
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Incyte USD 199.95M 1.49M 2026-03
Merck EUR 434.78M 0 2026-03
Neurocrine Biosciences USD 100.6M 500K 2026-03
Novartis USD 1.91B 60K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
UCB EUR 190.36M 365.15K 2025-12
Vertex Pharmaceuticals USD 254.2M 200K 2026-03